Range Biotechnologies


Range Biotechnologies is a company developing translational proteomics for the next stage of human health. They focus on scalable, targeted quantification of proteins to impact human health through diagnostics and drug development. The company is engaged in advancing proteomics research, including moving proteomics toward clinical applications and uncovering proteins in the dark proteome.

Industries

biotechnology
health-care
life-science

Nr. of Employees

small (1-50)

Range Biotechnologies

733 Industrial Rd, San carlos, CA


Services

Research and development services focused on targeted protein quantification and the translation of protein biomarkers to diagnostic and drug-development use cases.

Expertise Areas

  • Translational proteomics
  • Targeted protein quantification
  • Biomarker discovery and validation
  • Proteomics-enabled diagnostics and drug development
  • Show More (2)

Key Technologies

  • Proteomics
  • Targeted protein quantification
  • Biomarker discovery workflows
  • Proteomics data analysis

News & Updates

With the Potential to Revolutionize Personalized Health, Range Biotechnologies Receives $5.2 Million in Seed Funding Led by TechBio-Focused ARTIS Ventures.

Brian Gormley of The Wall Street Journal discussed ARTIS Ventures' portfolio companies including Range Biotechnologies in the field of protein research.

Range Biotechnologies is developing translational proteomics for human health, with interviews highlighting their work.

Range Bio believes that impactful human health advancements require scalable, targeted protein quantification alongside biomarker discovery.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.